New Antibody Removes Tregs to Boost Immune Response Against Cancer
Treg play a deleterious role in the tumor microenvironment by suppressing anti-tumor effector T cells."... read more
November 19, 2025
Tagged: T Cell
CDR3s and Renalase-1 Correlate with Increased Melanoma Survival
Our group has demonstrated that chemical complementarity between tumor resident, T-cell receptor, complementarity-determining region 3 (... read more
September 26, 2024
Behind the Study: Treatment Responses to Metronomic Cyclophosphamide
Researcher Mary Janatpour describes the findings in a paper she helped authored in Oncotarget, entitled "... read more
February 1, 2021